Literature DB >> 17292427

Cardiovascular risk factors in the urban Mexican population: the FRIMEX study.

E Meaney1, A Lara-Esqueda, G M Ceballos-Reyes, J Asbun, A Vela, Y Martínez-Marroquín, V López, A Meaney, E de la Cabada-Tamez, O Velázquez-Monroy, R Tapia-Conyer.   

Abstract

BACKGROUND: Atherosclerotic ischaemic heart disease is the second leading cause of general mortality in Mexico due to the growing prevalence of atherosclerotic risk factors in our society. The data of the FRIMEX study (Factores de Riesgo en México, Risk Factors in Mexico), considered together with those of other contemporary epidemiological surveys, will aid in our comprehension of the current state of cardiovascular epidemics in Mexico.
METHODS: Frequencies of obesity, hypertension and smoking, and total cholesterol and glucose in capillary blood were estimated in a non-probabilistic sample comprised of 140017 individuals (aged 44+/-13 years; 42% men and 58% women), from six Mexican cities (Mexico City, Guadalajara, Monterrey, Puebla, Leon and Tijuana).
RESULTS: Obesity or overweight status was found in 71.9% of participants. Hypertension was found in 26.5%, and the proportions of awareness, treatment and control for this disease were 49.3, 73 and 36%, respectively. Prevalence of hypertension increased with age; while it was higher in men under 60 years of age, in the more aged individuals it was higher in women. Hypercholesterolaemia was found in 40% of the individuals and cholesterolaemia > or =240 mg/dl was significantly higher in women. Thirty-five and a half percent of men and 18.1% of women were smokers. Type 2 diabetes mellitus was found in 10.4% of participants. There was significant Pearson's correlation between body mass index and blood pressure, between hypertension and glucose levels, and between hypertension and total cholesterol concentrations.
CONCLUSIONS: We conclude that this population has a high cardiovascular risk profile and a high probability of the occurrence of metabolic syndrome.

Entities:  

Mesh:

Year:  2007        PMID: 17292427     DOI: 10.1016/j.puhe.2006.11.008

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  6 in total

1.  The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans.

Authors:  Daphna Weissglas-Volkov; Anna C Calkin; Teresa Tusie-Luna; Janet S Sinsheimer; Noam Zelcer; Laura Riba; Ana Maria Vargas Tino; Maria Luisa Ordoñez-Sánchez; Ivette Cruz-Bautista; Carlos A Aguilar-Salinas; Peter Tontonoz; Päivi Pajukanta
Journal:  J Clin Invest       Date:  2011-07-18       Impact factor: 14.808

2.  Does metformin increase paraoxonase activity in patients with the metabolic syndrome? Additional data from the MEFISTO study.

Authors:  Eduardo Meaney; Patricia Sierra-Vargas; Alejandra Meaney; Martín Guzmán-Grenfell; Israel Ramírez-Sánchez; Juan Jose Hicks; Ivonne Olivares-Corichi; Guillermo Ceballos
Journal:  Clin Transl Sci       Date:  2012-06       Impact factor: 4.689

3.  Identification of two common variants contributing to serum apolipoprotein B levels in Mexicans.

Authors:  Daphna Weissglas-Volkov; Christopher L Plaisier; Adriana Huertas-Vazquez; Ivette Cruz-Bautista; Daniela Riaño-Barros; Miguel Herrera-Hernandez; Laura Riba; Rita M Cantor; Janet S Sinsheimer; Carlos A Aguilar-Salinas; Teresa Tusie-Luna; Päivi Pajukanta
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-12-03       Impact factor: 8.311

Review 4.  From Sea to Shining Sea and the Great Plains to Patagonia: A Review on Current Knowledge of Diabetes Mellitus in Hispanics/Latinos in the US and Latin America.

Authors:  M Larissa Avilés-Santa; Uriyoán Colón-Ramos; Nangel M Lindberg; Josiemer Mattei; Francisco J Pasquel; Cynthia M Pérez
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-10       Impact factor: 5.555

Review 5.  Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent.

Authors:  M Larissa Avilés-Santa; Alberto Monroig-Rivera; Alvin Soto-Soto; Nangel M Lindberg
Journal:  Curr Diab Rep       Date:  2020-10-10       Impact factor: 4.810

6.  Effect of APOB gene polymorphisms on body mass index, blood pressure, and total cholesterol levels: A cross-sectional study in Mexican population.

Authors:  Ana Gabriela Colima Fausto; Jaqueline Topete; Juan Ramón González García; Teresita de Jesús Hernández Flores; Sergio Yair Rodríguez Preciado; María Teresa Magaña Torres
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.